These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1712975)

  • 1. Enhancement of anticancer agent activity by selective inhibition of rapidly proliferating tissues of the host.
    Stolfi RL; Martin DS
    Pharmacol Ther; 1991; 49(1-2):43-54. PubMed ID: 1712975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists.
    Brandes LJ; LaBella FS; Warrington RC
    J Natl Cancer Inst; 1991 Sep; 83(18):1329-36. PubMed ID: 1886159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-histidinol increases the vulnerability of cultured human leukemia and lymphoma cells to anticancer drugs.
    Warrington RC; Cheng I; Zhang L; Fang WD
    Anticancer Res; 1993; 13(6A):2107-12. PubMed ID: 8297120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of L-histidinol on the susceptibility of P815 mastocytoma cells to selected anticancer drugs in vitro and in DBA/2J mice.
    Warrington RC; Cheng I; Fang WD
    J Natl Cancer Inst; 1987 Jun; 78(6):1177-83. PubMed ID: 3108563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach for improving the efficacy of experimental cancer chemotherapy using combinations of anticancer drugs and L-histidinol.
    Warrington RC
    Anticancer Res; 1986; 6(3 Pt B):451-64. PubMed ID: 3090929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of human colon carcinoma cells to anticancer drugs is enhanced by L-histidinol.
    Warrington RC; Cheng I; Fang WD
    Anticancer Res; 1994; 14(2A):367-72. PubMed ID: 8017835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
    Warrington RC; Fang WD
    J Natl Cancer Inst; 1985 May; 74(5):1071-7. PubMed ID: 3858576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.
    Wadler S; Schwartz EL
    Cancer Res; 1990 Jun; 50(12):3473-86. PubMed ID: 1692761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined effects of 5-fluorouracil and interferon on proliferation of human neoplastic cells in culture].
    Miyoshi T; Ogawa S; Kanamori T; Nobuhara M; Kimoto T; Namba M
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2207-11. PubMed ID: 6191694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-histidinol protection against cytotoxic action of cytosine arabinoside and 5-fluorouracil in cultured mouse spleen cells.
    Warrington RC; Fang WD
    J Natl Cancer Inst; 1982 Feb; 68(2):279-86. PubMed ID: 6950159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L-histidinol on the proliferation and anticancer drug susceptibility of cultured B16f10 melanoma cells.
    Warrington RC; Cheng I; Fang W
    Anticancer Res; 1991; 11(5):1863-7. PubMed ID: 1768057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo studies on potentiation of cytotoxic effects of anticancer drugs or cobalt 60 gamma ray by interferon on human neoplastic cells.
    Namba M; Yamamoto S; Tanaka H; Kanamori T; Nobuhara M; Kimoto T
    Cancer; 1984 Nov; 54(10):2262-7. PubMed ID: 6207909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-histidinol reverses resistance to cisplatinum and other antineoplastics in a tumorigenic epithelial cell line.
    Warrington RC; Fang WD; Zhang LU
    Anticancer Res; 1996; 16(6B):3641-6. PubMed ID: 9042235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-histidinol in experimental cancer chemotherapy: improving the selectivity and efficacy of anticancer drugs, eliminating metastatic disease and reversing the multidrug-resistant phenotype.
    Warrington RC
    Biochem Cell Biol; 1992 May; 70(5):365-75. PubMed ID: 1353969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potentiation of the cytotoxic effects of various anticancer drugs by interferon on human neoplastic cells (HeLa) in culture].
    Namba M; Yamamoto S; Tanaka H; Kanamori T; Nobuhara M; Kimoto T
    Gan To Kagaku Ryoho; 1983 May; 10(5):1308-12. PubMed ID: 6191681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity, schedule, and proliferation dependence of infused L-histidinol after 5-fluorouracil in mice.
    Edelstein MB; Heilbrun LK
    Cancer Res; 1988 Mar; 48(6):1470-5. PubMed ID: 3345520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental chemotherapy and concepts related to the cell cycle.
    Tannock IF
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Feb; 49(2):335-55. PubMed ID: 3510996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-histidinol selectively modulates daunomycin toxicity in normal and tumorigenic kidney epithelial cells.
    Warrington RC; Fang WD; Zhang L; Shieh M; Saier MH
    Anticancer Res; 1996; 16(6B):3629-33. PubMed ID: 9042233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of L-histidinol to improve the therapeutic efficiency of 5-fluorouracil against murine breast tumors.
    Stolfi RL; Sawyer RC; Martin DS
    Cancer Res; 1987 Jan; 47(1):16-20. PubMed ID: 3791203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies on potentiation of cytotoxic effects of anticancer drugs by interferon on a human neoplastic cell line (HeLa).
    Yamamoto S; Tanaka H; Kanamori T; Nobuhara M; Namba M
    Cancer Lett; 1983 Sep; 20(2):131-8. PubMed ID: 6199106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.